The Comparison of Tricuspid Replacement and Repair in Patients With Combined Heart Valve Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

1998-01-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Functional tricuspid regurgitation is common in patients with heart valve disease, replacement and repair both can correct this anomaly. However, there is no data to address which one can bring more benefits to these patients with combined heart valve disease. The investigators retrospectively review patients with two or more heart valve disease and functional tricuspid regurgitation, and assess its long term outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

we reviewed patients who admitted to our hospital due to combined heart valve disease, and underwent tricuspid valve replacement or repair from January,1998 to december,2009. we made a comparison between these two groups, in term of early results after operation and long term results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tricuspid Valve Regurgitation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

tricuspid valve regurgitation replacement repair outcomes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Repair group

patients in repair group underwent tricuspid repair for functional tricuspid regurgitation.

No interventions assigned to this group

replacement group

In this group, patients underwent tricuspid valve replacement for functional tricuspid regurgitation.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Significant disorders in aortic and mitral valves
* Moderate ～ severe tricuspid regurgitation
* Underwent tricuspid repair or replacement operation

Exclusion Criteria

* Isolate tricuspid valve lesion
* Mild tricuspid valve regurgitation
* Tricuspid valve regurgitation was left without surgical treatment

Minimum Eligible Age

21 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

the departement of cardiovascular surgery, xijing hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

zhang jinzhou, MD

Role: PRINCIPAL_INVESTIGATOR

Xijing Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhang Jinzhou

Xi'an, Shaanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20101012

Identifier Type: -

Identifier Source: org_study_id